Imaging biomarkers of NAFLD, NASH, and fibrosis

Background: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non-alcoholic steatohepatitis (NASH). Liver biopsy is invasive, subject to sampling and interobserver variability, and impracti...

Full description

Bibliographic Details
Main Authors: Veeral Ajmera, Rohit Loomba
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Molecular Metabolism
Subjects:
MRI
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877821000077

Similar Items